+149.2%
MRNA vs FGI
-37.7%
+186.9%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | FGI | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | +6.0% | -10.8% | -4.9% |
| 7D | -20.9% | -41.9% | +21.0% | -20.8% |
| 30D | -13.3% | -35.5% | +22.3% | -13.2% |
| 3M | +212.6% | -50.7% | +263.3% | +212.8% |
| 6M | +309.0% | -1.5% | +310.5% | +300.5% |
| YTD | +567.3% | -19.1% | +586.4% | +545.4% |
| 1Y | +689.7% | -15.4% | +705.1% | +659.8% |
| All | +149.2% | -37.7% | +186.9% | +143.5% |
Cumulative growth
Daily Returns
Daily percentage return beside FGI.
Daily Out/Under-Performance
Portfolio return minus FGI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FGI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded FGI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling